Journals / The anatolian journal of family medicine (Online) / 2021 / Cilt: 4 - Sayı: 1

Severe COVID-19 is Caused by an Overreacting Immune System: Highly Dosed Corticosteroids Could be a Lifesaver!

Pages
106–107
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
🔖

Cite This Article

SİEGERSMA, J. E. (2021). Severe COVID-19 is Caused by an Overreacting Immune System: Highly Dosed Corticosteroids Could be a Lifesaver!. The anatolian journal of family medicine (Online), Cilt: 4 - Sayı: 1, 106–107. https://ajindex.com/articles/365004

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Johns Hopkins University & Medicine. Coronavirus Re- source Center. Available at: https://coronavirus.jhu.edu/ map.html. Accessed Oct 27, 2020
  2. Zaim S, Chong JH, Sankaranarayanan V, Harky A. COVID-19 and multiorgan response. Curr Probl Cardiol 2020;45(8):100618
  3. Bikdeli B, Madhavan MV, Jimenez D, Chuich T, Dreyfus I, Driggin E,; Global COVID-19 Thrombosis Collaborative Group, Endorsed by the ISTH, NATF, ESVM, and the IUA, Supported by the ESC Working Group on Pulmonary Circulation and Right Ventricular Function. COVID-19 and thrombotic or thromboembolic disease: implica- tions for prevention, antithrombotic therapy, and fol- low-up: JACC state-of-the-art review. J Am Coll Cardiol 2020;75(23):2950–73
  4. Jones VG, Mills M, Suarez D, Hogan CA, Yeh D, Segal JB, et al. COVID-19 and Kawasaki disease: novel virus and novel case. Hosp Pediatr 2020;10(6):537–40
  5. Nelson P, Rylance P, Roden D, Trela M, Tugnet N. Viruses as potential pathogenic agents in systemic lupus ery- thematosus. Lupus 2014;23(6):596–605
  6. WHO. Clinical management of COVID-19. Interim guid- ance. 27 May 2020. Available at: https://www.who.int/ publications/i/item/clinical-management-of-covid-19. Accessed May 27, 2020
  7. University of Oxford. News and events. Dexamethasone reduces death in hospitalised patients with severe res- piratory complications of COVID-19. Available at: http:// www.ox.ac.uk/news/2020-06-16-dexamethasone-reduces-death-hospitalise- d-patients-severe-respiratory-complications. Accessed June 16, 2020
  8. RECOVERY Collaborative Group, Horby P, Lim WS, Em- berson JR, Mafham M, Bell JL, et al. Dexamethasone in hospitalized patients with Covid-19 - Preliminary report. N Engl J Med. 2020 Jul 17. doi: 10.1056/NEJMoa2021436. [Epub ahead of print]
  9. Dall'Era M, Wofsy D. Clinical Manifestations of Systemic Lupus Erythematosus. Firestein GS, Budd RC, Gabriel SE, MacInnes IB, O’Dell JR, eds. Kelley and Firestein's Text- book of Rheumatology. 10th ed. Philadelphia, Pa: Else- vier Saunders; 2017. 1345-67
  10. Chowdhary VR. Broad Concepts in Management of Systemic Lupus Erythematosus. Mayo Clin Proc. 2017 May;92(5):744-761.